| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Comprehensive loss | -105,496 | -208,643 | -133,701 | -72,498 |
| Basic net (loss) income per common share | -1.17 | -2.4 | -1.58 | -1.01 |
| Diluted net (loss) income per common share | -1.17 | -2.4 | -1.58 | -1.01 |
| Weighted average number of shares outstanding, basic, total | 91,305,337 | 87,069,690 | 85,938,720 | 85,234,926 |
| Weighted average number of shares outstanding, diluted | 91,305,337 | 87,069,690 | 85,938,720 | 85,234,926 |
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)